Oct. 22, 2029 -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has expanded the label for Fiasp? (insulin aspart injection) 200 u/mL to include use in insulin infusion pumps for the improv……
23 September 2029 07:00 BST AstraZeneca today announced that Qtrilmet (metformin hydrochloride, saxagliptin and dapagliflozin) modified-release tablets have been recommended for marketing authorisation in ……
September 20, 2029 ― Almirall LLC announced today the FDA approval of the expanded indication for Aczone? 7.5% Gel to include patients aged 9-22. Aczone? 7.5% Gel is a prescription medicine used on the skin (topical) to ……
Aug. 30, 2029 -- CARsgen Therapeutics Inc., a clinical-stage biopharmaceutical company today announced the United States Food and Drug Administration (FDA) has granted orphan drug designation to its investiga……
ORTH CHICAGO, Illinois, Aug. 2, 2029 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the European Commission has granted marketing authorization for MAVIRET? (……
JERUSALEM and PARSIPPANY, N.J., July 25, 2029 ? Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved AirDuo? Digihaler? (flutic……
Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 蘇ICP備12056923號-1
Tel: 025-82232955 025-82232966
Fax:025-82232933 025-82232944
E-mail: info@dorrapharma.com
